If you study Hlt balance sheet very very very carefully you will discover that Hlt has increased it's Cash investment by Rm19 millions to Rm28 millions
Hlt cash position has increased tremendously
But due to its deployment into short term investments it is not shown up as cash profit instead it showed up an increased of Nav from 10 sen to 12 sen
If we look at it's true cash position then this quarter profit is 3.76 sen 31/08/2020 4:51 PM
???is that 9 mil considered as revenue in the first place?????or current asset???woahhh what a spin, any accountant/auditor can clarify this????? The picture is getting clearer. Mikecyc vs the singapore? Who's the real good guy and who's the real bad guy????
Op-Ed: Why a PPE shortage still plagues America and what we need to do about it PUBLISHED SAT, AUG 22 202010:00 AM EDT Dan Cohen, CEO of 3DBio Therapeutics
KEY POINTS Six months into the Covid-19 crisis, there is still a dire shortage of personal protective equipment for our health-care workers, says Dan Cohen, CEO of 3DBio Therapeutics.
America needs a dynamic ecosystem of U.S.-based medical production called a Manufacturing Reserve Corps. that can kick into gear during any health-care emergency.
Six months into the Covid-19 crisis, there is still a dire shortage of personal protective equipment (PPE) for our health-care workers, particularly those on the front lines of the coronavirus pandemic. Doctors and nurses are still reusing single use N-95s and experiencing shortages of face shields and gloves. How did this happen in a country ranked No. 1 in pandemic preparedness by the WHO, one which comprises 40% of total global pharma spending, and represents 24% of global economic output?
At the start of the crisis, the federal government’s Strategic National Stockpile included 12 million N95 masks and 30 million surgical masks, about 1% of the 3.5 billion required in the U.S. in the first year of the pandemic.
The reason for the shortage was clear then: a reliance on outsourcing PPE manufacturing to China. The White House had to order 500 million respirators from China, and received a delivery timeline of 18 months or more. But despite the efforts of major U.S. companies and innovative entrants shifting to produce PPE (HanesBrands, Tesla), why has this shortage persisted?
Because there are already signs that PPE manufacturers are ramping down production to avoid the risk of holding surplus inventory. With the prospect of another wave of Covid cases in the fall, this could lead to additional shortages.
Hospitals’ PPE costs will top $3.8 billion in second half of 2020
As the co-founder and CEO of 3DBio Therapeutics, which 3-D bioprints medical implants end-to-end in New York City, when Covid-19 began I wanted to help. I witnessed firsthand the PPE shortage doctors, nurses and other health-care workers had to deal with at the height of the crisis that endangered their safety. In response, we pivoted and worked nights and weekends to build a Powered Air-Purifying Respirator (PAPR), under the moniker American PAPR. PAPRs, crucial PPE for medical professionals treating infectious disease, consist of a hooded plastic mask and breathing tube that block 99.97% of small particles. PAPRs were most famously worn by the doctors in the movie “Outbreak.”
What is hampering PPE supplies We were honored to be one of only a handful of manufacturers (alongside Ford) to receive rapid regulatory approval from the National Institute for Occupational Safety and Health (NIOSH). But the main obstacles we have faced in getting PPE to medical professionals are the three same core issues that have stymied American ingenuity and productivity during this crisis.
First, budget shortfalls have been an issue for hospitals throughout the pandemic, because critical care and inpatient services are their least profitable areas. Hospitals nationwide lost over $161 billion due to canceled procedures from March to June 2020, while uninsured visits rose 114%. This has resulted in limited budgets for PPE.
Second, unpredictability in demand creates further risk to producing PPE. Existing players or new entrants like us need to create capacity by investing to expand production. Yet in the midst of a crisis, demand is hard to predict, given budget challenges and high degrees of local volatility as the curve flattens or regions spike. In a chaotic market, there is substantial risk to your primary business if your investment in production mistimes demand.
Lastly, concerns about fraud tie hospitals to familiar manufacturers. Regulatory authorities, including the FDA and NIOSH, have been heroic in shortening timelines to get safe PPE into the hands of health-care workers. But inundated by a barrage of unreliable PPE imported from China, institutions cannot easily discern quality products from counterfeit. Unpredictable pandemic-led demand surges require nimble and local U.S. manufacturing, but hospitals face liabilities in working with new entrants.
Sometime a share up or down , it depends on Institute or foreign investors whether to Goreng it up or not.. Not depends on your Mickeys or Mickeys Gang Bad Mouth Words.
Dr Fauci Warns Covid19 could get "Multiple Times" Worse
"It's something that is so difficult to predict because it—really much of it— depends on what we ourselves are doing in the sense of the public health measures necessary to contain the outbreak. Now, one of the problems is that as we've seen the most effective way to do that is to essentially shut down the problem with shutting down and staying shut down for a prolonged period of time, is that that adds to extraordinary economic instability….Now, if we, as a global community, pull together and try to reopen for those that have essentially shut down in a prudent and careful manner that doesn't allow resurgences and rebounds of cases, then we could actually do fairly well, or at least much better than the projections are now."
DLLM99_kyy Hi Mickey Mouse, Vinvest institute saying Glove is uptrend … So, what is your explanation now ? 31/08/2020 10:07 PM
Then v ll c si-fool Mickey MOUTH to further promote for HLT 365 days since hardselling 24/7 sleepless. I am here bcos of her bad MOUTH promotion. Tqvm si-fool Mickey, just for right time to top up to enjoy the big ride coming 2molo.
We knew a lot of BS but this was known about its ineffectiveness!!!!
Scientists see downsides to top COVID-19 vaccines from Russia, China Allison Martell, Julie Steenhuysen 5 MIN READ
TORONTO/CHICAGO (Reuters) - High-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed to, potentially limiting their effectiveness, some experts say.
FILE PHOTO: A logo of China's vaccine specialist CanSino Biologics Inc is pictured on the company's headquarters in Tianjin, following an outbreak of the coronavirus disease (COVID-19), China August 17, 2020. REUTERS/Thomas Peter/File Photo CanSino Biologics’ vaccine, approved for military use in China, is a modified form of adenovirus type 5, or Ad5. The company is in talks to get emergency approval in several countries before completing large-scale trials, the Wall Street Journal reported last week.
A vaccine developed by Moscow’s Gamaleya Institute, approved in Russia earlier this month despite limited testing, is based on Ad5 and a second less common adenovirus.
“The Ad5 concerns me just because a lot of people have immunity,” said Anna Durbin, a vaccine researcher at Johns Hopkins University. “I’m not sure what their strategy is ... maybe it won’t have 70% efficacy. It might have 40% efficacy, and that’s better than nothing, until something else comes along.”
Covid 19 cannot be eradicated completely - Koon Yew Yin - Koon Yew Yin's Blog | I3investor
Author: Koon Yew Yin Publish date: Mon, 31 Aug 2020, 10:25 AM
I have excerpted Dr Sheldon Campbell’s useful article for investors. Based on this article, the demand for medical gloves will continue to exceed supply. The selling prices for gloves will continue to go up higher and higher which should be reflected on glove stocks prices.
As COVID-19 cases continue to pile up across the country, many of us are wondering when—and if—the highly infectious and potentially deadly virus is ever going to go away. According to a top Yale pathologist, the answer is no. It is going to be with us "indefinitely."
"It's going to tail off, not end abruptly," Sheldon Campbell, MD, Ph.D., a laboratory medicine specialist at Yale Medicine and professor of laboratory medicine at Yale School of Medicine, tells Eat This, Not That! Health. "I think COVID-19 will be with us indefinitely." Read on to find out what they are, and to get through this pandemic at your healthiest, don't miss these Sure Signs You've Already Had Coronavirus.
'We're Unlikely to Eradicate It"
Dr. Campbell explains that despite the fact that the measles vaccine was developed in 1963 (enhanced in 1968 and MMR in '71), is "absolutely superb," fifty years later it is still not eradicated. "COVID is quite infectious, there are many asymptomatic cases to maintain it in a population, so we're unlikely to eradicate it like we did SARS," he adds.
And while top researchers like Francis Collins and Anthony Fauci are optimistic that a vaccine will be ready in 2021, he points out that there are still a lot of questions. "Will a vaccine block transmission or merely attenuate or limit symptoms? How many doses, how far apart? How effective will it be at preventing illness/death/transmission (each of those is a different number; the last one particularly hard to get at). And very critically, how many people will take it?" he asks.
As far as the testing realm, his area of interest, there are a lot of ideas sparking curiosity that could significantly improve the efficiency of testing—which could be incredibly beneficial as complementary approaches to controlling the virus. "Emerging technologies might produce a self-administered test that would detect high viral loads (the most infectious state) for around a dollar. They'd not detect every positive; but maybe most highly-infectious people," he reveals.
The Doctor's "Perhaps-Optimistic" Scenario
His best-case "perhaps-optimistic" scenario in achieving "new normal" status goes like this:
"The country figures out that, hey, masks aren't that awful—seems to be happening now to a degree. This current surge levels off and slowly declines because of social distancing, but bursts of infection continue in various places; possibly more so come winter. The vaccine trials go well. A trickle of cheap, rapid tests is also becoming available and are used in populations without vaccine coverage. We find and isolate patients sooner. Levels of disease decline to those seen in Europe now, say. New outbreaks are quickly contained, and the country gradually moves to a 'new normal' about a year from now."
How to Avoid COVID-19
Do what the scientists say: Wear your face mask, get tested if you think you have coronavirus, avoid crowds (and bars, and house parties), practice social distancing, only run essential errands, wash your hands regularly, disinfect frequently touched surfaces, and to get through this pandemic at your healthiest, don't miss these 37 Places You're Most Likely to Catch Coronavirus.
Some Russian teachers fear back-to-school shots of 'Sputnik V' COVID vaccine
Olesya Astakhova, Polina Nikolskaya
3 Min Read
MOSCOW (Reuters) - A small independent Russian teachers’ union is urging members not to be coerced into accepting shots of the “Sputnik V” coronavirus vaccine which is to be mandatory for military personnel.
FILE PHOTO: A scientist dilutes samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in Saint Petersburg, Russia June 11, 2020. REUTERS/Anton Vaganov/File Photo
Moscow clinics last week began receiving supplies of the vaccine, which has been approved for use inside Russia even though the final Phase III tests, involving 40,000 people, began only last Wednesday.
From September, doctors and teachers will be among the first to be offered the jab on a voluntary basis, officials have said, an arrangement President Vladimir Putin has said he supports.
Defence Minister Sergei Shoigu has said shots of the vaccine will be made mandatory for military personnel.
With Russian schools re-opening on Sept. 1 for the first time since March, the teachers’ union Uchitel has launched an online petition against making the vaccine mandatory for teachers before all clinical trials are complete.
“It’s likely that school principals will be under pressure for everyone to be vaccinated,” the petition says.
Uchitel represents only about 700 of Russia’s 1.2 million school teachers, a senior union official said, but it says nearly 1,400 people have signed its petition.
The Health Ministry said vaccination would be voluntary and redirected other questions to the Education Ministry, which did not reply to a request for a comment.
The Moscow mayor’s office said any trials would be on a voluntary basis and that “there is no pressure on schools and therefore, no punishment measures towards teachers.” Uchitel is the only teachers’ union known to have issued such a petition.
But Uchitel’s co-chair, Marina Baluyeva, an English-language teacher from St Petersburg, drew parallels with occasional weekends when staff are asked to help do clean-up work, saying this work was voluntary in theory but that teachers who decline to do the work can get into trouble.
WARNINGS BY WESTERN EXPERTS
Russia is the first country to license a COVID-19 vaccine, calling it “Sputnik V” in homage to the world’s first satellite, launched by the Soviet Union. Western experts have warned against its use until all internationally approved testing and regulatory steps have been taken. Moscow has dismissed such criticism as an information war.
One Moscow school has already offered voluntary shots to its nearly 80 teachers, several staff at the school said. One of the teachers, Larisa Ivanovna, said 20 had signed up for the jab but that her decision was driven by fear of losing their job.
“I am afraid of taking the risk of an untested vaccine,” said Dmitry Kazakov, a history teacher who signed the Uchitel petition and is wary even though his bosses have not asked him to have the jab. “Sometimes you get an offer you cannot reject.”
Reporting by Olesya Astakhova, Polina Nikolskaya and Maria Vasilyeva; Additional reporting by Maria Tsvetkova, Darya Korsunskaya and Polina Ivanova, Writing by Katya Golubkova, Editing by Sujata Rao, Andrew Osborn and Timothy Heritage
Hi Si-Pondan Mickey, I think you should continue post the Data you Calculate , Found.. To influence us.. I saw Supermx comments Winter is coming bla bla bla .. Covid 19 will mutation.. I wonder you go each counter and ruin their share price..
in Pharma group , I saw negative comments.. Dunno why..
WORLD NEWS AUGUST 31, 2020 / 10:09 PM / UPDATED 43 MINUTES AGO
Some Russian teachers fear back-to-school shots of 'Sputnik V' COVID vaccine Olesya Astakhova, Polina Nikolskaya MOSCOW (Reuters) - A small independent Russian teachers’ union is urging members not to be coerced into accepting shots of the “Sputnik V” coronavirus vaccine which is to be mandatory for military personnel.
FILE PHOTO: A scientist dilutes samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in Saint Petersburg, Russia June 11, 2020. REUTERS/Anton Vaganov/File Photo Moscow clinics last week began receiving supplies of the vaccine, which has been approved for use inside Russia even though the final Phase III tests, involving 40,000 people, began only last Wednesday.
From September, doctors and teachers will be among the first to be offered the jab on a voluntary basis, officials have said, an arrangement President Vladimir Putin has said he supports.
Defence Minister Sergei Shoigu has said shots of the vaccine will be made mandatory for military personnel.
With Russian schools re-opening on Sept. 1 for the first time since March, the teachers’ union Uchitel has launched an online petition against making the vaccine mandatory for teachers before all clinical trials are complete.
“It’s likely that school principals will be under pressure for everyone to be vaccinated,”
Uchitel represents only about 700 of Russia’s 1.2 million school teachers, a senior union official said, but it says nearly 1,400 people have signed its petition.
The Health Ministry said vaccination would be voluntary and redirected other questions to the Education Ministry, which did not reply to a request for a comment.
The Moscow mayor’s office said any trials would be on a voluntary basis and that “there is no pressure on schools and therefore, no punishment measures towards teachers.” Uchitel is the only teachers’ union known to have issued such a petition.
But Uchitel’s co-chair, Marina Baluyeva, an English-language teacher from St Petersburg, drew parallels with occasional weekends when staff are asked to help do clean-up work, saying this work was voluntary in theory but that teachers who decline to do the work can get into trouble.
WARNINGS BY WESTERN EXPERTS Russia is the first country to license a COVID-19 vaccine, calling it “Sputnik V” in homage to the world’s first satellite, launched by the Soviet Union. Western experts have warned against its use until all internationally approved testing and regulatory steps have been taken. Moscow has dismissed such criticism as an information war.
One Moscow school has already offered voluntary shots to its nearly 80 teachers, several staff at the school said. One of the teachers, Larisa Ivanovna, said 20 had signed up for the jab but that her decision was driven by fear of losing their job.
“I am afraid of taking the risk of an untested vaccine,” said Dmitry Kazakov, a history teacher who signed the Uchitel petition and is wary even though his bosses have not asked him to have the jab. “Sometimes you get an offer you cannot reject.”
Reporting by Olesya Astakhova, Polina Nikolskaya and Maria Vasilyeva; Additional reporting by Maria Tsvetkova, Darya Korsunskaya and Polina Ivanova, Writing by Katya Golubkova, Editing by Sujata Rao, Andrew Osborn and Timothy Heritage
Our Standards:The Thomson Reuters Trust Principles. REUTERS NEWS NOW
hahaha.. Mickey Si-Pondan, FInally I can be like you, find solid Data for India Corona Virus.. I can now answer you Why HLT export on 4,5,6 is such that weak and coming 7,8,9 will extremely Full Force and Strong already!
hahaha... Due to China & Thailand not so impact, we don't account them. Indonesia is a small potion, I don't account that. I focus on India Export.
1/4-30/4 Covid 19 Cases -- 1792 to 24641= total : 22849 1/5-31/5 Covid 19 Cases -- 24641 to 93349 = total : 68708 1/6-30/6 Covid 19 Cases -- 93350 to 220546 = total : 127196
Total for 2nd QR India Total cases is 218753 cases increase...
Summary for July 2020 and August 2020 as Below:
1/7-31/7 Covid 19 Cases -- 220547 to 546856 = 326310 1/8-30/8 Covid 19 Cases -- 564857 to 781624 = 216767
Total for only 3rd 2 months Total Cases is 543077 .
4,5,6 2nd QR HLT net profit let say 6 million for India cases 218753 .
7,8 (excluded September 2020 because we don't know yet how severe India Now) Covid cases is 547077.
If using 1:1 calculation , HLT should be earning double now profit if Full Force producing..
If using July & August total Data to divide 2nd QR amount is 543077 / 218753 = 2.500889
Hence at here,
6 million is Darab or X or Times 2.500889 will be equal to ??? 15 Million.. Hi, we not yet calculate September delivery as we don't the India Data cases how severe now.. As now 1 day 80K Covid 19 Cases..
So I can guarantee here 3rd QR onwards HLT Income Net Profit will be 15 million and Above !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
I not yet include Indonesia is coming up Covid 19 cases .. If add in Indonesia, I believe the net prodit would not at 15 million.. I believe HLT worth at least RM4 and above!
Note : FY20 (1Q) ended March export sales revenue is reduced by 40.3 % .. not a good sign either.
31/08/2020 10:32 PM
Please refer to my Solid Data, Why Export Reduce by March onwards,
Because that time HLT concentrate on Local supply and India Covid Cases is not that strong .. I believe India got their Own Glove factory as well that's why don't need so much Import from HLT.
But 7,8,9 I don't think HLT export stagnant at quantity between 4,5,6 oh...
Si-Pondan Mickey..
Use your Brain to think oh.. Hahaha..
that's interesting case study ..
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Jo1234
194 posts
Posted by Jo1234 > 2020-08-31 21:25 | Report Abuse
https://www.investing.com/news/coronavirus/scientists-see-downsides-to-top-covid19-vaccines-from-russia-china-2281118